National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment
National and State Treatment Need and Capacity for Opioid Agonist Medication-Assisted Treatment
复制标题
DOI：
10.2105/ajph.2015.302664
复制
发表时间：
2015-08-01
影响因子：
12.7
通讯作者：
McCance-Katz, Elinore
中科院分区：
文献类型：
--
作者：
Jones, Christopher M.;Campopiano, Melinda;McCance-Katz, Elinore
目标.我们估计了阿片类激动剂药物辅助治疗（OA-MAT）需求和能力的国家和州趋势，以确定差距并为政策决策提供信息。我们生成了国家和州过去一年阿片类药物滥用或依赖率，最大潜在丁丙诺啡治疗能力，从阿片类药物治疗计划（OTP）接受美沙酮的患者数量，以及使用药物滥用和精神卫生服务管理局数据以80%或更高容量运行的OTP的百分比。在全国范围内，2012年，阿片类药物滥用或依赖率为每10万名12岁或12岁以上的人中有891.8人，而全国最大潜在丁丙诺啡治疗能力和接受美沙酮治疗的患者的比率分别为420.3和119.9。在各州和哥伦比亚特区中，96%的阿片类药物滥用或依赖率高于其丁丙诺啡治疗能力率; 37%的差距至少为每1000人5人。38个州（77.6%）报告至少75%的OTP以80%或更高的容量运行。在州和国家一级，治疗需求与能力之间存在着巨大差距。需要采取战略增加OA-MAT提供者的数量。
Objectives. We estimated national and state trends in opioid agonist medication-assisted treatment (OA-MAT) need and capacity to identify gaps and inform policy decisions.Methods. We generated national and state rates of past-year opioid abuse or dependence, maximum potential buprenorphine treatment capacity, number of patients receiving methadone from opioid treatment programs (OTPs), and the percentage of OTPs operating at 80% capacity or more using Substance Abuse and Mental Health Services Administration data.Results. Nationally, in 2012, the rate of opioid abuse or dependence was 891.8 per 100 000 people aged 12 years or older compared with national rates of maximum potential buprenorphine treatment capacity and patients receiving methadone in OTPs of, respectively, 420.3 and 119.9. Among states and the District of Columbia, 96% had opioid abuse or dependence rates higher than their buprenorphine treatment capacity rates; 37% had a gap of at least 5 per 1000 people. Thirty-eight states (77.6%) reported at least 75% of their OTPs were operating at 80% capacity or more.Conclusions. Significant gaps between treatment need and capacity exist at the state and national levels. Strategies to increase the number of OA-MAT providers are needed.